Stock REXAHN PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Rexahn Pharmaceuticals, Inc. Nyse

Equities

US7616401011

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Rexahn Pharmaceuticals, Inc.

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Rexahn Pharmaceuticals : Announces Expected Effectiveness of Reverse Stock Split and Merger Transaction with Ocuphire Pharma
AQ
Rexahn Pharmaceuticals : Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma
AQ
REXAHN PARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Rexahn Pharmaceuticals, Inc. - REXN
BU
Rexahn and Ocuphire Enter into Definitive Merger Agreement
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. News Rexahn Pharmaceuticals, Inc.
  6. Highlights